Literature DB >> 10458683

Does local therapy affect survival rates in breast cancer?

H S Shukla1, J Melhuish, R E Mansel, L E Hughes.   

Abstract

BACKGROUND: The goal of this study was to challenge the hypothesis that local recurrence of breast cancer does not affect survival rates, by determining whether survival rates differ for conservative and radical surgical policies.
METHODS: This study used prospective long-term follow-up monitoring of two contemporaneous groups of patients, within a single unit, who were treated identically except for the one variable of local treatment policy, i.e., conservative or radical. A total of 451 patients with operable breast cancer were chosen from 567 consecutive patients with breast cancer who were treated between 1970 and 1979 in the University Department of Surgery. The rate of survival 132 months after treatment was used as an outcome measure.
RESULTS: Two hundred forty-one patients were treated using a conservative approach and 210 were treated using a radical approach. At 132 months, the survival rate (58% vs. 42%) and median survival time (> 132 vs. 100 months) were significantly improved for the radically treated group (P < .01). The treatment groups were comparable in terms of age, menopausal status, tumor size, histologic grading, and Nottingham Prognostic Index values. The advantage of the radical policy persisted when examined in relation to each of these prognostic factors.
CONCLUSIONS: Use of radical local treatment yielded a highly significant survival benefit (comparable to that obtained with adjuvant therapy), compared with a conservative approach. This was related to a reduced locoregional recurrence rate and provides evidence that local therapy influences long-term outcomes for patients with breast cancer. High-quality locoregional control should be emphasized, as is systemic therapy, in management policies. Assessment of surgical techniques, particularly in relation to locoregional recurrence rates, should be included in all studies in which surgery is a component of therapy.

Entities:  

Mesh:

Year:  1999        PMID: 10458683     DOI: 10.1007/s10434-999-0455-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  3 in total

1.  Effect of prevailing local treatment options of breast cancer on survival outside controlled clinical trials: experience of a specialist breast unit in North India.

Authors:  Mallika Tewari; S Pradhan; M Kumar; H S Shukla
Journal:  World J Surg       Date:  2006-10       Impact factor: 3.352

2.  Which patients need an axillary clearance after sentinel node biopsy?

Authors:  Anastasia Pazaiti; Ian S Fentiman
Journal:  Int J Breast Cancer       Date:  2011-08-24

3.  Overexpression of P70 S6 kinase protein is associated with increased risk of locoregional recurrence in node-negative premenopausal early breast cancer patients.

Authors:  J A van der Hage; L J C M van den Broek; C Legrand; P C Clahsen; C J A Bosch; E C Robanus-Maandag; C J H van de Velde; M J van de Vijver
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.